Benchmark Holdings

(BMK)
Sector: Pharmaceuticals & Biotechnology
36.25p
-1.20p -3.20
Last updated: 16:36:07

Share information

Name Benchmark Holdings
Epic BMK
Isin GB00BGHPT808
Index AIM50 AIM350
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 36.25p Net gearing n/a
Market capitalisation £268.17 Debt ratio n/a
Shares in issue 739.75 Debt-to-equity ratio n/a
P/E ratio n/a Assets / equity ratio n/a
Total dividends per share n/a Price to book value n/a
Dividend yield n/a ROCE -3.64
Dividend cover n/a EPS growth n/a
Earning per share -4.6 52-week high / low 34.00p / 48.00p

Dividends

Type Ex-date Pay-date Net-dividend
No dividends declared

Contact details

Company name Benchmark Holdings
Address Highdown House, Yeoman Way, Worthing, West Sussex, United Kingdom, BN99 3HH
Telephone
Website http://www.bmkholdings.com

Directors

Director Position
Mr Trond Williksen CEO
Mrs Septima Maguire CFO
Mr Peter George Chairman
Mr Jonathan Esfandi Non-Executive Director
Mr Yngve Myhre Non-Executive Director
Mr Torgeir Svae Non-Executive Director
Mr Marie Danielsson Non-Executive Director
Mr Kristian Eikre Non-Executive Director
Ms Jennifer Haddouk Company Secretary

Company financials

Assets £ (m) 2022 2021 2020
Reporting date 30/09/22 30/09/21 30/09/20
Intangible asssets and goodwill 245.26 229.04 247
Investments and other non-current assets 0.01 0.01 0.02
Total non-current assets 378.2 357.96 343.29
Inventory / work in progress 29.81 20.95 18.93
Trade and other receivables 56.38 46.5 39.37
Cash and equivalents 36.4 39.46 71.61
Other current assets and asset held for resale 25.78 17.12 15.85
Total of all assets 526.57 481.99 489.04
Liabilities £ (m) 2022 2021 2020
Short term liabilities 73.26 63.52 55.37
Long term liabilities 130.03 138.87 138.22
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 203.29 202.39 193.59
Net assets £ (m) 2022 2021 2020
Net assets 323.29 279.6 295.44
Equity £ (m) 2022 2021 2020
Share capital 0.7 0.67 0.67
Minority interests 9.89 7.88 6.31
Retained earnings 77.7 30.46 -142.17
Share premium account 420.82 400.68 n/a
Total equity 323.29 279.6 295.44
Income £ (m) 2022 2021 2020
Turnover n/a n/a n/a
Operating profit -7.86 -5.38 -11.02
Pre-tax profit -23.18 -9.18 -22.57